PMGC Holdings (ELAB)
NASDAQ:ELAB
Want to see ELAB full AI Analyst Report?
ELAB Stock Chart & Stats
$1.55
-$0.19(-8.12%)
At close: 4:00 PM EST
$1.55
-$0.19(-8.12%)
Day’s Range― - ―
52-Week Range$1.34 - $309.12
Previous CloseN/A
Volume180.10K
Average Volume (3M)89.87K
Market Cap
$6.68M
Enterprise Value-$2.97M
Total Cash (Recent Filing)$15.09M
Total Debt (Recent Filing)$7.96M
Price to Earnings (P/E)―
Beta2.58
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,543,751
10 Day Avg. Volume35,159
30 Day Avg. Volume89,868
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.37
Price to Sales (P/S)4.90
P/FCF Ratio-0.45
Enterprise Value/Market Cap-0.44
Enterprise Value/Revenue-2.33
Enterprise Value/Gross Profit-18.41
Enterprise Value/Ebitda0.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundA sharp TTM revenue rebound (~+116% YoY) signals renewed commercial traction and stronger top-line momentum across PMGC’s businesses. Durable revenue growth can enable scale, improve fixed-cost absorption and create a pathway to margin recovery if management sustains customer wins and integrates recent acquisitions effectively.
Long-term Aerospace Supply ContractsMulti-year supply agreements with aerospace/defense customers provide recurring revenue visibility and high switching costs. Coupled with quality and compliance commitments, these contracts support predictable cash flows, justify capex for capacity, and strengthen PMGC’s positioning as a qualified Tier supplier in a regulated, high-barrier market.
Committed Acquisition FundingA $40M equity purchase facility (initial tranche ~ $9.7M net) provides committed capital to execute roll-ups and investments in precision manufacturing and defense tech. This durable funding line enhances strategic optionality to pursue accretive acquisitions, accelerate integration, and invest in certifications that underpin long-term industrial growth.
Bears Say
Persistent Cash BurnConsistent negative operating and free cash flow (TTM OCF ≈ -$7.6M; FCF ≈ -$7.9M) indicates the business lacks internal cash generation and is dependent on external financing. Over months this constrains reinvestment, raises refinancing risk and forces prioritization of cash uses, making sustainable growth contingent on funding or rapid margin improvement.
Rising LeverageDebt increasing materially (to ~$8.0M from ~$2.6M) and debt/equity ≈0.60 reduces financial flexibility and raises servicing and covenant risk. Higher leverage limits the company’s ability to weather downturns, may increase financing costs, and makes future acquisitions or R&D investments more dependent on equity issuance or costly credit.
Thin Gross Margins & Large LossesA thin gross margin (~13% TTM) alongside extreme operating and net losses implies structural profitability problems in core operations. Without durable margin expansion—via pricing, mix shift, or operational synergies—ongoing losses will erode equity and require continual financing, hindering the company’s long-term ability to self-fund growth.
PMGC Holdings News
ELAB FAQ
What was PMGC Holdings’s price range in the past 12 months?
PMGC Holdings lowest stock price was $1.34 and its highest was $309.12 in the past 12 months.
What is PMGC Holdings’s market cap?
PMGC Holdings’s market cap is $6.68M.
When is PMGC Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PMGC Holdings’s earnings last quarter?
Currently, no data Available
Is PMGC Holdings overvalued?
According to Wall Street analysts PMGC Holdings’s price is currently Overvalued.
Does PMGC Holdings pay dividends?
PMGC Holdings does not currently pay dividends.
What is PMGC Holdings’s EPS estimate?
PMGC Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PMGC Holdings have?
PMGC Holdings has 4,543,751 shares outstanding.
What happened to PMGC Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PMGC Holdings?
Currently, no hedge funds are holding shares in ELAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PMGC Holdings
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
Technical Analysis
Biodexa Pharmaceuticals
―
―
Indaptus Therapeutics
―
InMed Pharmaceuticals
―
CNS Pharmaceuticals
―
Ownership Overview
73.43%
Insiders
― Other Institutional Investors
26.57% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---